|Login
Ground News Logo
Sep 25, 2021SUBSCRIBE NOW

FDA grants historic approval to Alzheimer’s drug from Biogen

The landmark decision has been eagerly awaited by millions but will be hotly contested by some experts doubt the drug’s effectiveness.
4 months ago|Washington, United States

BIAS COVERAGE DISTRIBUTION

164 of these news sources are bias rated
78 are CENTER
L 31%
C 48%
R 21%
CNN
HuffPost
Raw Story
MSNBC
+1
The Guardian
CBC News
Global News
The Hindu
+44
BBC News
Reuters
CTV News
CNBC
+75
Times of India
Washington Times
Independent.ie
The Telegraph
+24
Russia Today
Newsmax
Anadolu Ajansı
The Daily Wire
+5
ALL ARTICLES
Yahoo News
Yahoo News

Biotech Shares Soar as Biogen Drug Approval Stokes Optimism

(Bloomberg) -- The approval of Biogen Inc.’s new Alzheimer’s disease treatment spurred broad gains in the sector, driving the Nasdaq Biotech Index to surge by the most in seven months.Shares of Eli Lilly & Co. jumped 10% and closed at a record high, while Biogen’s partner in Japan, Eisai Co., surged 56% in U.S. trading, the biggest gain ever for the stock. Small-cap companies working on treatments for the disease also climbed: Cassava Sciences I…

4 months ago|Los Angeles, United States
Times of India
Times of IndiaR

US FDA approves Biogen Alzheimer's drug

US News: US regulators on Monday approved Biogen Inc's aducanumab as the first treatment to address an underlying cause of Alzheimer's disease despite controve.

4 months ago|Mumbai, India
BBC News
BBC NewsC

US approves first new Alzheimer's drug in 20 years

There has been controversy around aducanumab, which targets the cause rather than the symptoms.

4 months ago|United Kingdom
The Guardian
The GuardianL

FDA to announce its decision on new Alzheimer’s drug

Usefulness of aducanumab is disputed but US approval will trigger push to make it available globallyA new drug for Alzheimer’s disease, the first in nearly 20 years, may be approved in the US on Monday, which would trigger pressure to make it available worldwide.Any decision is likely to be controversial. While doctors, patients and the organisations that support them are desperate for treatments that can slow mental deterioration, the usefulnes…

4 months ago|London, United Kingdom
CBC News
CBC NewsL

New Alzheimer's drug approved in U.S. despite concerns about effectiveness

U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease.

4 months ago|Canada
Reuters
ReutersC

U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big day" for patients

U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.

4 months ago|United Kingdom
News18 India
News18 India

US Approves First New Alzheimer's Drug in Almost Two Decades

The United States on Monday approved a drug called Aduhelm to treat patients with Alzheimer's, the first new medicine against the disease in almost two decades and the first to address cognitive decline linked to the condition.

4 months ago|India
Global News
Global NewsL

U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 years

It's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.

4 months ago|Toronto, Canada
CTV News
CTV NewsC

FDA approves much-debated Alzheimer's drug panned by experts

U.S. government health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease.

4 months ago|Toronto, Canada
The Hindu
The Hindu L

FDA conditionally approves controversial Alzheimer’s drug

The drug, a monoclonal antibody, is given monthly via injection to patients who suffer from early stages of the disease.

4 months ago|India
COVERAGE DETAILS

BIAS COVERAGE DISTRIBUTION

164 of these news sources are bias rated
78 are CENTER
L 31%
C 48%
R 21%
CNN
HuffPost
Raw Story
MSNBC
The Guardian
CBC News
Global News
The Hindu
NDTV
CBS Local
USA Today
The Independent
abc News
Hindustan Times
Sydney Morning Herald
+37
BBC News
Reuters
CTV News
CNBC
Associated Press News
IBTimes
RTÉ
The Hill
Channel News Asia
Sky News
Eurek Alert
+68
Times of India
Washington Times
Independent.ie
The Telegraph
Gulf News
Financial Post
MY Northwest
The Times
ITV
Al Arabiya
Las Vegas Review-Journal
+17
Russia Today
Newsmax
Anadolu Ajansı
The Daily Wire
CBN
wng.org
Fox News
Breitbart
Total News Sources307Leaning Left51 sourcesLeaning Right35 sourcesCenter78 sourcesLast Updated4 months ago
0
TOPICS
SIMILAR STORIES